Concert Pharmaceuticals Reports First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Concert Pharmaceuticals Reports First Quarter 2018 Financial Results

Concert Pharma (CNCE) Tops Q1 EPS by 39c

May 3, 2018 7:27 AM EDT

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.19), $0.39 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $10.5 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

... More